We could not find any results for:
Make sure your spelling is correct or try broadening your search.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells. PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.
Rezatapopt is a first-in-class precision oncology investigational therapy for patients with advanced solid tumors with a TP53 Y220C mutation and KRAS wild-type (WT)First patient dosed in Phase 2...
Phase 1 analysis from the PYNNACLE Phase 1/2 study showed promising efficacy of rezatapopt (PC14586) in heavily pre-treated patients with advanced ovarian cancer harboring a TP53 Y220C mutation...
Registrational, tumor-agnostic Phase 2 portion of PYNNACLE clinical trial of rezatapopt (PC14586), a first-in-class precision oncology investigational therapy in patients with advanced solid...
PRINCETON, N.J., Feb. 26, 2024 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.42 | 23.8636363636 | 1.76 | 2.21 | 1.725 | 729012 | 1.99715419 | CS |
4 | 0.62 | 39.7435897436 | 1.56 | 2.21 | 1.49 | 525265 | 1.79575145 | CS |
12 | 0.59 | 37.106918239 | 1.59 | 2.21 | 1.46 | 587462 | 1.72229258 | CS |
26 | 0.1 | 4.80769230769 | 2.08 | 3.47 | 1.46 | 528142 | 1.95682337 | CS |
52 | -2.71 | -55.4192229039 | 4.89 | 9.72 | 1.175 | 549892 | 3.33257782 | CS |
156 | -33.29 | -93.8539610939 | 35.47 | 37.3199 | 1.175 | 649052 | 12.22858288 | CS |
260 | -32.87 | -93.7803138374 | 35.05 | 63.22 | 1.175 | 569538 | 13.69938098 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions